MacroGenics, Inc.

₺205.67
TRY
Last updated on --.
24h volume1.05M
24h highest207.51 TRY
24h lowest197.63 TRY
24h Price movement-1.21%

MGNX recent prices

24 Hours
-1.21%-₺2.528
30 days
+45.90%+₺64.34
60 days
+53.92%+₺72.61
90 days
+124.75%+₺113.52

Key data

Previous close208.20 TRY
Market cap13.03B TRY
Volume1.05M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-51.0165 TRY
Net income (FY)-3.23B TRY
Revenue (FY)7.22B TRY
Last report dateMay 13, 2026

About MacroGenics, Inc.

PHARMACEUTICAL PREPARATIONS
HeadquartersRockville
Employees (FY)293.00
Revenue per employee (FY)24.64M TRY
Net income per employee (FY)-11.04M TRY
Listed onNasdaq
Official website

MGNX conversion tables

MGNXMGNX
TRYTRY
0.5 MGNX102.83 TRY
1 MGNX205.67 TRY
5 MGNX1,028.37 TRY
10 MGNX2,056.74 TRY
TRYTRY
MGNXMGNX
0.5 TRY0.002431 MGNX
1 TRY0.004862 MGNX
5 TRY0.02431 MGNX
10 TRY0.04862 MGNX

FAQ

MGNX is trading at ₺205.67, -1.21% over the last 24 hours. Track live moves on the price chart at the top of this page.
The MGNX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. MGNX is currently trading at ₺205.67, -1.21% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on MGNX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. MGNX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from MGNX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against MGNX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
MacroGenics, Inc.'s market cap is currently 13.03B TRY. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX TR does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX TR. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX TR does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.05M
24h highest207.51 TRY
24h lowest197.63 TRY
24h Price movement-1.21%
MGNXMGNX
TRYTRY
Start trade with MGNX Perpetual